Health Care ETFs Have Lost In The Last Month – These Top Pharma Stocks Are The Reason
The Health Care Select Sector SPDR Fund (NYSE:XLV), heavily tilted towards mega-caps, lost around 5.25% over the last month, with substantial companies…
Why Is TCR2 Therapeutics Stock Trading Higher Today?
TCR² Therapeutics (NASDAQ: TCRR) shares are trading higher on Monday after the company and Adaptimmune Therapeutics (NASDAQ: ADAP) announced an agreement under which the two companies will combine to create a cell
EF Hutton Reiterates Buy on Adaptimmune Therapeutics, Maintains $10 Price Target
EF Hutton analyst Tony Butler reiterates Adaptimmune Therapeutics (NASDAQ:ADAP) with a Buy and maintains $10 price target.
Earnings Scheduled For March 6, 2023
Companies Reporting Before The Bell
• Passage Bio (NASDAQ:PASG) is estimated to report earnings for its fourth quarter.
Publication Of Data From Adaptimmune’s Completed Phase 1 Trial With Afami-cel In Nature Medicine Demonstrating An Acceptable Safety Profile And Encouraging Responses In Synovial Sarcoma
-The response rate was 44% in patients with late-stage, metastatic synovial sarcoma after a single dose of afami-cel -
- Based on these results, the Company initiated a Phase 2 trial with afami-cel for people
Expert Ratings for Adaptimmune Therapeutics
Within the last quarter, Adaptimmune Therapeutics (NASDAQ:ADAP) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…
EF Hutton Initiates Coverage On Adaptimmune Therapeutics with Buy Rating, Announces Price Target of $10
EF Hutton analyst Tony Butler initiates coverage on Adaptimmune Therapeutics (NASDAQ:ADAP) with a Buy rating and announces Price Target of $10.
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers Invacare (NYSE:IVC) stock rose 14.3% to $0.48 during Friday’s after-market session. The market value of their outstanding…
Credit Suisse, Autodesk And Other Big Losers From Wednesday
U.S. stocks closed higher on Wednesday, with the Nasdaq Composite gaining more than 100 points. Here is the list of some big stocks recording losses in the previous session.